Megan Edge

Megan Edge has a diverse work experience spanning multiple industries. Megan began their career as a Speech Language Pathologist at Warm Springs - a subsidiary of Post Acute Medical in August 2015 and continued in that role until January 2016. In January 2016, they joined St. David's HealthCare as a Speech Language Pathologist, where they gained valuable experience managing patients with dysphagia and cognitive-communication disorders in various healthcare settings. Megan'sresponsibilities included performing Fiberoptic Endoscopic Evaluation of Swallowing (FEES) and Modified Barium Swallow Studies (MBSS), as well as implementing hospital-wide changes for compliance with the International Dysphagia Diet Standardization Initiative (IDDSI). In May 2021, Megan transitioned to GLG, a global insight network, where they held multiple positions in the BioPharma division. Megan served as a Senior Associate, Client Solutions until January 2022, where they provided valuable client solutions and support. From January 2022 to April 2022, they worked as a Research Manager, focusing on the BioPharma industry. Megan then assumed the role of an Account Manager, specializing in BioPharma, from April 2022 to September 2022. Currently, Megan is working as an Account Executive at BrainCheck, starting in September 2022.

Megan Edge holds a Master of Science (MS) degree in Speech-Language Pathology/Pathologist from Texas State University. Prior to their Master's degree, they obtained a Bachelor of Science (B.S.) in Communication Sciences and Disorders, General from the same institution. In addition, Megan has a Certificate of Clinical Competence from The American Speech-Language-Hearing Association (ASHA), although the specific month and year of obtaining this certification are not mentioned.